2014 HIV/AIDS Surveillance in the European Union and European Economic Area (EU/EEA) European Centre for Disease Prevention and Control, Stockholm WHO.

Slides:



Advertisements
Similar presentations
2013 HIV/AIDS Surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.
Advertisements

HIV Surveillance – Persons Who Inject Drugs National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention.
Surveillance report Annual Epidemiological Report on communicable diseases in Europe ECDC Surveillance Unit European Centre for Disease Prevention and.
2012 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.
THE EUROPEAN UNION. HISTORY 28 European states after the second world war in 1951 head office: Brussels 24 different languages Austria joined 1995.
Sexual transmission of HIV amongst migrant populations in Europe: managing change in surveillance, interventions and prevention V.Delpech and Teymur Noori.
Map - Region 3 Europe.
HIV surveillance in Northern Ireland 2013 An analysis of data for the calendar year 2012.
Ecdc.europa.eu Estonian Ministry of Social Affairs 23 November 2007 Zsuzsanna Jakab Director, ECDC Press Briefing on HIV/AIDS.
2010 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.
Ecdc.europa.eu Epidemiological Situation of HIV/AIDS in the EU and its Neighbouring Countries German Presidency Conference Responsibility & Partnership.
Computer Class – Summer 20092/21/2016 3:45 AM European Countries Albania Andorra Austria Belarus Belgium Bosnia and Herzegovina Bulgaria Croatia Czech.
The European Law Students’ Association Albania ˙ Austria ˙ Azerbaijan ˙ Belgium ˙ Bosnia and Herzegovina ˙ Bulgaria ˙ Croatia ˙ Cyprus ˙ Czech Republic.
Table 1. Numbers and rates of TB cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based Source:
Table 1. Criteria for differentiating acute and chronic hepatitis C Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological.
Table 1. Number and rate of reported confirmed syphilis cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate,
Table 1. Number and rate of Legionnaires’ disease cases per population by country and year, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based.
CONFIDENTIAL 1 EPC, European Union and unitary patent/UPC EPC: yes EEA: no EU: no (*) (*) Also means no unitary patent Albania, Macedonia, Monaco, San.
Table 1. Criteria for differentiating acute and chronic hepatitis B Suggested citation: European Centre for Disease Prevention and Control. Annual epidemiological.
2013 HIV/AIDS Surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.
Surveillance of hepatitis B and C in the EU/EEA
Epidemiology of STIs (including HIV and HBV infections) in undocumented migrants in Europe: what do we know? Andrew Amato, Head of HIV/STI/Hepatitis Programme,
Table 1. Confirmed cases of Typhoid and paratyphoid fever: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y.
Rome Cardiology Forum 2014 Update on life-style and cardiovascular prevention The dimension of the problem Rome Cardiology Forum January 29, 2014.
Retirement Age Reform: Issues to Consider in Russian Federation
Table 1. New HIV diagnoses by country, EU/EEA, 2010–2014
Table 1. Reported confirmed hepatitis A cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =
DISTRIBUTION AUTOMATIC - GENERATION
Sexually Transmitted Infections in Europe, 2012
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
Figure 1. Number of reported hantavirus infection cases, EU/EEA, 2014
HIV surveillance in Northern Ireland 2014
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
Cases Rate National data Report type
Table 1. Reported, confirmed campylobacteriosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes,
Table 1. Number and rate of reported confirmed syphilis cases per 100 000 population by country and year, EU/EEA, 2010–2014 Country
Table 1. Reported confirmed brucellosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =
The European Parliament – voice of the people
The European Parliament – voice of the people
Tuberculosis situation in the EU/EEA, 2016
HIV/AIDS Surveillance in Europe 2011
Gonorrhoea cases of gonorrhoea were reported by 27 EU/EEA Member States for The overall notification rate was 18.8 cases per 100 000 population.
Brief overview of HIV among MSM in the EU/EEA
EU: First- & Second-Generation Immigrants
Table 1. Table 1. Reported confirmed salmonellosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y.
Sexually Transmitted Infections in Europe
Country Cases Rate National data Report type
Table 1. Number and rate of reported confirmed gonorrhoea cases per population, EU/EEA, 2010–2014 Country Cases Rate Austria.
Table 1. Reported confirmed VTEC infection cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N.
Table 1. Reported confirmed cholera cases, EU/EEA, 2010–2014
Leaving no-one behind UNAIDS.
Table 1. Number and rate of reported confirmed chlamydia cases per population, EU/EEA, 2010–2014 Country Cases Rate Austria.
Table 1. Reported confirmed botulism cases: number and rate per population, EU/EEA, 2010–2014 ASR: age-standardised rate, C: case-based Source:
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS Surveillance in Europe
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
Table 1. Reported confirmed leptospirosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N.
European Union Membership
Chlamydia In 2016, cases of chlamydia infection were reported in 26 EU/EEA Member States. The overall notification rate was 184 per 100 000 persons.
Surveillance of hepatitis B and C in the EU/EEA – 2016 data
Table 1. Confirmed cases of trichinellosis: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N = no,
Global estimates for adults and children, 2014
Trends for ECDC measles and rubella monitoring,
Table 1. Reported confirmed listeriosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =
Tuberculosis situation in the EU/EEA, 2017
Table 1. Table 1. Reported confirmed toxoplasmosis cases: number and rate per live births, EU/EEA, 2010–2014 Source: Country reports. Legend: Y.
Source: Country reports
Annual Epidemiological Report for 2017 Sexually Transmitted Diseases - chlamydia - gonorrhoea - lymphogranuloma venereum - (congenital) syphilis.
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017
Table 1. Reported confirmed yersiniosis cases: number and rate per population, EU/EEA, 2010–2014 Source: Country reports. Legend: Y = yes, N =
Presentation transcript:

2014 HIV/AIDS Surveillance in the European Union and European Economic Area (EU/EEA) European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen

HIV diagnoses in the EU/EEA, 2014 Reporting countries/Number of countries31/31 Number of HIV diagnoses Rate per population (adjusted rate * )5.9 (6.4) Percentage age years11.1 Male-to-female ratio3.3 Transmission mode (%) Sex between men42 Heterosexual 33 Injecting drug use4 Mother to child transmission <1<1 Unknown 20 Source: ECDC/WHO (2015). HIV/AIDS Surveillance in Europe, 2014 * Rate adjusted for reporting delay for the most recent year of reporting due to the lag in cases being reported to European level in some countries

New HIV diagnoses, 2014, EU/EEA > to <20 2 to <10 < 2 Not included or not reporting Liechtenstein Luxembourg Malta Non-visible countries Rate per population Source: ECDC/WHO (2015). HIV/AIDS Surveillance in Europe, 2014 EU/EEA rate 5.9 per * * EU rate adjusted for reporting delay is 6.4 per

Male-to-female ratio, new HIV diagnoses, by country, EU/EEA, 2014 (n= ) Source: ECDC/WHO (2015). HIV/AIDS Surveillance in Europe, 2014

HIV diagnoses in women, 2014, EU/EEA > to <20 2 to <10 < 2 Not included or not reporting Liechtenstein Luxembourg Malta Non-visible countries Rate per female population Source: ECDC/WHO (2015). HIV/AIDS Surveillance in Europe, 2014 EU/EEA rate 2.6 per

> to <20 2 to <10 < 2 Not included or not reporting Liechtenstein Luxembourg Malta Non-visible countries HIV diagnoses in men, 2014, EU/EEA Rate per male population Source: ECDC/WHO (2015). HIV/AIDS Surveillance in Europe, 2014 EU/EEA rate 9.2 per

Percentage of HIV diagnoses, by route of transmission, 2014, EU/EEA Source: ECDC/WHO (2015). HIV/AIDS Surveillance in Europe, 2014

Age- and gender-specific rates of new HIV diagnoses, EU/EEA, 2014 (n=29 923) Source: ECDC/WHO (2015). HIV/AIDS Surveillance in Europe, 2014 Men Women

Number of new HIV diagnoses, by age group and transmission mode, EU/EEA, 2014 (n=23 747) Injecting drug use Heterosexual Sex between men Data from people <15, other/unknown transmission, mother-to-child transmission, transfusion-related transmission, and nosocomial transmission not shown here. Source: ECDC/WHO (2015). HIV/AIDS Surveillance in Europe, 2014

Percentage of new HIV diagnoses with known mode of transmission, EU/EEA, 2014 (n= ) 9 Injecting drug use Heterosexual Sex between men Other Source: ECDC/WHO (2015). HIV/AIDS Surveillance in Europe, 2014 Unknown mode of transmission is excluded from proportions presented here. Countries reporting only one case in 2014 (Liechtenstein and Iceland) are not presented here.

> 5 3 to <5 1 to <3 < 1 Not included or not reporting Liechtenstein Luxembourg Malta Non-visible countries HIV diagnoses attributed to sex between men, 2014, EU/EEA Rate per male population Source: ECDC/WHO (2015). HIV/AIDS Surveillance in Europe, 2014

> 5 3 to <5 1 to <3 < 1 Not included or not reporting Liechtenstein Luxembourg Malta Non-visible countries HIV diagnoses acquired through injecting drug use, 2014, EU/EEA Rate per population Source: ECDC/WHO (2015). HIV/AIDS Surveillance in Europe, 2014

Proportion HIV diagnoses among migrants * by country of report, EU/EEA, 2014 (n= ) Source: ECDC/WHO (2015). HIV/AIDS Surveillance in Europe, 2014 New diagnoses in people originating from countries with generalised HIV epidemics New diagnoses in people originating from other countries * Migrants are all persons born outside of the country in which the diagnosis was made. Data presented here are among cases with known region of origin; There were no cases reported among migrants in Hungary, Liechtenstein, Poland or Romania

New HIV diagnoses, by CD4 cell count per mm 3 at diagnosis and transmission mode, EU/EEA, Source: ECDC/WHO (2015). HIV/AIDS Surveillance in Europe, 2014 >500 cells/mm to <350 cells/mm 3 < 200 cells/mm to <500 cells/mm 3

New HIV diagnoses, by CD4 cell count per mm 3 at diagnosis and region of origin of the case, EU/EEA, Source: ECDC/WHO (2015). HIV/AIDS Surveillance in Europe, 2014 >500 cells/mm to <350 cells/mm 3 < 200 cells/mm to <500 cells/mm 3

> 50% 40 to 50% 30 to <40% < 30% Not included or not reporting Liechtenstein Luxembourg Malta Non-visible countries Proportion of HIV cases diagnosed late (CD4<350 cells/mm 3 ), 2014, EU/EEA *Among cases with CD4 count at diagnosis reported Source: ECDC/WHO (2015). HIV/AIDS Surveillance in Europe, 2014

New HIV and AIDS diagnoses per , , EU/EEA

HIV diagnoses, by mode of transmission, , EU/EEA Data is adjusted for reporting delay. Cases from Estonia and Poland excluded due to incomplete reporting on transmission mode during the period; cases from Italy and Spain excluded due to increasing national coverage over the period. Source: ECDC/WHO (2015). HIV/AIDS Surveillance in Europe, 2014 Injecting drug use Heterosexual (women) Heterosexual (Men) Sex between men Mother-to-child transmission Other/ undetermined

HIV diagnoses, by mode of transmission, , EU/EEA Data is adjusted for reporting delay. Cases from Estonia and Poland excluded due to incomplete reporting on transmission mode during the period; cases from Italy and Spain excluded due to increasing national coverage over the period. Source: ECDC/WHO (2015). HIV/AIDS Surveillance in Europe, 2014

Median CD4 cell count per mm 3, by transmission group, EU/EEA, Excludes countries with >60% incomplete data on CD4 cell count during any year over the period (Belgium, Bulgaria, Croatia, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Latvia, Lithuania, Malta, Norway, Poland, Portugal, Slovak Republic, Sweden) Source: ECDC/WHO (2015). HIV/AIDS Surveillance in Europe, 2014 Injecting drug use Heterosexual Sex between men

AIDS diagnoses, by transmission mode, EU/EEA, Cases from Sweden excluded due to inconsistent reporting during the period Source: ECDC/WHO (2015). HIV/AIDS Surveillance in Europe, 2014 Injecting drug use Heterosexual Other/ undetermined Sex between men

21 Conclusions (1) HIV infection is of major public health importance in the EU/EEA, with no clear signs of overall decrease. During the past decade ( ) there have been important epidemiological changes in HIV diagnoses in the EU/EEA:  Sex between men accounted for the majority of cases diagnosed in 2014 (42%) and is increasing  Heterosexual cases declined, driven by a decline among those from countries with generalised HIV epidemics  Still, 37% of HIV diagnoses in 2014 were among people originating from outside the reporting country  HIV cases attributed to injecting drug use declined over the last decade, despite the increase in two countries due to localised outbreaks Nearly half (47%) of persons diagnosed had a CD4 cell count of <350/mm 3 at diagnosis.

Conclusions (2) Evidence-based HIV prevention interventions tailored to the local epidemiological context and targeted at those most at risk should be sustained and scaled-up. Programmes for men who have sex with men should be a cornerstone of HIV prevention in all EU/EEA countries Given the high proportion of HIV cases among migrants in many EU/EEA countries, and evidence of post-migration HIV- acquisition, migrant-sensitive prevention services are crucial Keeping harm reduction levels high will continue to prevent HIV among people who inject drugs Expansion of HIV counselling and testing will ensure early diagnosis and access to treatment; this will reduce the number of late presenters and improve treatment outcomes. 22

23 Full report and tables and can be downloaded at: